Gastroenterology

The AJMC® Gastroenterology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the stomach, digestive tract, colon, and more.

Latest News

AJMC
Corticosteroid Premedication for Infliximab Remains Unnecessarily Common

July 8th 2025

Although use of corticosteroid premedication prior to infliximab infusions is declining, it remains unnecessarily high despite limited benefit and the risk of serious adverse events from corticosteroids.

child with IBD | Image credit: Art_Photo - stock.adobe.com
Increasing Biosimilar Use Reflects Changing Practice in Pediatric IBD Care

June 25th 2025

Pediatric CD. | Image Credit: mandm. - stock.adobe.com
Upadacitinib Offers Effective Induction for Pediatric Crohn Disease, Safety Profile Requires Scrutiny

June 14th 2025

Inflammatory bowel disease. | Image Credit: Kiattisak - stock.adobe.com
Protein Signatures for Predicting Future Crohn Disease and Ulcerative Colitis Diagnoses

June 10th 2025

stem cells for IBD | Image credit: pinkeyes - stock.adobe.com
Stem Cell Transplant Offers Hope for Children With Severe Monogenic IBD

June 2nd 2025

Continuing Medical Education
View All
August 12th 2025

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases
August 12th 2025

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

1.5 Credits / Endocrinology, Diabetes & Metabolism, Gastroenterology
August 12th 2025

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology, Immunology
August 12th 2025

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

1.5 Credits / Gastroenterology
August 12th 2025

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

1.5 Credits / Gastroenterology, Immunology

More News

guy with stomach discomfort after eating bread, celiac | Image credit: weyo - stock.adobe.com
January 23rd 2025

Gene Variant, Season of Birth Identified as Celiac Disease Risk Factors

Skylar Jeremias
Children born in spring or summer with a specific gene variant may have a higher risk of celiac disease and lower levels of a key protein, according to a study, potentially helping future research on autoimmune diseases.
positive covid-19 test | Image credit: JOE LORENZ DESIGN - stock.adobe.com
January 14th 2025

Study Finds Link Between COVID-19 and Elevated Risk of GI Disorders

Skylar Jeremias
A study found that patients with COVID-19 may have a higher risk of developing new gastrointestinal (GI) disorders compared with matched controls, highlighting the need for further research on long-term GI effects post COVID-19 infection.
norovirus test | Image credit: jarun011 - stock.adobe.com
January 14th 2025

Entering Peak Norovirus Season as Cases Rise Across the US

Sophia Abene
Nationwide norovirus cases have recently increased, followed by an FDA warning for consumers to avoid oysters contaminated in a recent outbreak.
digestive tract and IBS/IBD | Image credit: Grispb - stock.adobe.com
January 13th 2025

What Adjunct Therapies Are Most Effective for IBS, IBD?

Skylar Jeremias
A study suggests that adjunct therapies, including the Mediterranean diet, physical activity, and cognitive behavioral therapy, may help alleviate persistent digestive symptoms and improve quality of life for patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), alongside standard drug treatments.
digestive trouble doll | Image credit: Alrandir - stock.adobe.com
January 9th 2025

Prucalopride Tablets for Chronic Idiopathic Constipation Launches, Approved for 180-Day CGT Designation

Gillian McGovern
The tablets are indicated for treatment of adults with chronic idiopathic constipation, with further research needed to assess efficacy and safety in children.
inflammatory bowel disease | Image credit: Aliaksandr Marko - stock.adobe.com
January 7th 2025

Stable Patient Satisfaction Found After Switching From Humira or Biosimilar Adalimumab to CT-P17

Deana Ferreri, PhD
A real-world study in France found patient satisfaction was stable after switching from either the reference product or a low-concentration adalimumab biosimilar to the adalimumab biosimilar CT-P17, a high-concentration, citrate-free formulation.
<12

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo